ADVERSE REACTIONS SECTION.
Sincerus Florida, LLC. Adverse reactions. zz.
Citing DrugCentral © 2024. License
COMPONENTS.
Active, inactive. s.
Citing DrugCentral © 2024. License
INSTRUCTIONS FOR USE SECTION.
Directions for use. d.
Citing DrugCentral © 2024. License
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL.
NDC 72934-1050-2 CLINDAMYCIN PHOSPHATE USP 1% NIACINAMIDE USP 2% TAZAROTENE 0.05%. Gel 30gm. d.
Citing DrugCentral © 2024. License